These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 11024529)

  • 1. Characterization of T cell receptor (TCR) of organ-specific autoimmune disease-inducing T cells and TCR-based immunotherapy with DNA vaccines.
    Matsumoto Y
    J Neuroimmunol; 2000 Oct; 110(1-2):1-12. PubMed ID: 11024529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful TCR-based immunotherapy for autoimmune myocarditis with DNA vaccines after rapid identification of pathogenic TCR.
    Matsumoto Y; Jee Y; Sugisaki M
    J Immunol; 2000 Feb; 164(4):2248-54. PubMed ID: 10657681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CDR3 size spectratyping and sequencing of spectratype-derived TCR of spinal cord T cells in autoimmune encephalomyelitis.
    Kim G; Tanuma N; Kojima T; Kohyama K; Suzuki Y; Kawazoe Y; Matsumoto Y
    J Immunol; 1998 Jan; 160(1):509-13. PubMed ID: 9552010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of autoimmune encephalomyelitis-associated common CDR3 sequences by CDR3 spectratyping and subsequent DNA hybridization.
    Jee Y; Matsumoto Y
    J Neuroimmunol; 2002 May; 126(1-2):37-49. PubMed ID: 12020955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunity to T cell receptor peptides: theory and applications.
    Offner H; Hashim GA; Vandenbark AA
    Regul Pept; 1994 May; 51(2):77-90. PubMed ID: 8059014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New approach to immunotherapy against organ-specific autoimmune diseases with T cell receptor and chemokine receptor DNA vaccines.
    Matsumoto Y
    Curr Drug Targets Immune Endocr Metabol Disord; 2005 Mar; 5(1):73-7. PubMed ID: 15777206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis and assessment of preclinical and clinical autoimmune encephalomyelitis using peripheral blood lymphocyte TCR.
    Kim G; Kohyama K; Tanuma N; Matsumoto Y
    Eur J Immunol; 1998 Sep; 28(9):2751-9. PubMed ID: 9754562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The trimolecular complex as a target for specific immunotherapy in experimental autoimmune encephalomyelitis--applications for multiple sclerosis and other human autoimmune disease].
    Miller A; Weiner HL; Abramsky O
    Harefuah; 1992 Aug; 123(3-4):110-5. PubMed ID: 1516860
    [No Abstract]   [Full Text] [Related]  

  • 9. Persistent expression of experimental autoimmune encephalomyelitis (EAE)-specific Vbeta8.2 TCR spectratype in the central nervous system of rats with chronic relapsing EAE.
    Kim G; Kohyama K; Tanuma N; Arimito H; Matsumoto Y
    J Immunol; 1998 Dec; 161(12):6993-8. PubMed ID: 9862735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of T cell receptor associated with the development of P2 peptide-induced autoimmune neuritis.
    Matsumoto Y; Kim G; Tanuma N
    J Neuroimmunol; 2000 Jan; 102(1):67-72. PubMed ID: 10626668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the antigen specificity and TCR repertoire, and TCR-based DNA vaccine therapy in myelin basic protein-induced autoimmune encephalomyelitis in DA rats.
    Miyakoshi A; Yoon WK; Jee Y; Matsumoto Y
    J Immunol; 2003 Jun; 170(12):6371-8. PubMed ID: 12794171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complementarity-determining region 3 spectratyping analysis of the TCR repertoire in multiple sclerosis.
    Matsumoto Y; Yoon WK; Jee Y; Fujihara K; Misu T; Sato S; Nakashima I; Itoyama Y
    J Immunol; 2003 May; 170(9):4846-53. PubMed ID: 12707368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fine T cell receptor repertoire analysis of spinal cord T cells responding to the major and minor epitopes of myelin basic protein during rat autoimmune encephalomyelitis.
    Matsumoto Y; Jee Y; Sugisaki M; Kim G; Tanuma N
    J Neurosci Res; 2000 Jan; 59(1):145-52. PubMed ID: 10658195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of costimulation in autoimmune demyelination.
    Racke MK; Ratts RB; Arredondo L; Perrin PJ; Lovett-Racke A
    J Neuroimmunol; 2000 Jul; 107(2):205-15. PubMed ID: 10854658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tracking of V beta 8.2-positive encephalitogenic T cells by complementarity-determining region 3 spectratyping and subsequent Southern blot hybridization in Lewis rats after neuroantigen sensitization.
    Sakuma H; Kohyama K; Jee Y; Matsumoto Y
    J Immunol; 2004 Oct; 173(7):4516-22. PubMed ID: 15383583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunization with a synthetic T-cell receptor V-region peptide protects against experimental autoimmune encephalomyelitis.
    Vandenbark AA; Hashim G; Offner H
    Nature; 1989 Oct; 341(6242):541-4. PubMed ID: 2477708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccines for multiple sclerosis: progress to date.
    Correale J; Farez M; Gilmore W
    CNS Drugs; 2008; 22(3):175-98. PubMed ID: 18278975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclonal antibody therapy in experimental allergic encephalomyelitis and multiple sclerosis.
    Zhang X; Hupperts R; De Baets M
    Immunol Res; 2003; 28(1):61-78. PubMed ID: 12947225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T-cell based immunotherapy in experimental autoimmune encephalomyelitis and multiple sclerosis.
    O'Brien K; Gran B; Rostami A
    Immunotherapy; 2010 Jan; 2(1):99-115. PubMed ID: 20231863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T cell receptor peptides in treatment of autoimmune disease: rationale and potential.
    Vandenbark AA; Hashim GA; Offner H
    J Neurosci Res; 1996 Feb; 43(4):391-402. PubMed ID: 8699526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.